Contemporary Considerations in Multiple Sclerosis Treatment: A Post-Pandemic Educational Curriculum MedPointsTM in Multiple Sclerosis DMTs and COVID-19
Webcast
0.5 AMA PRA Category 1 Credit™ ...OVERVIEW
Contemporary Considerations in Multiple Sclerosis Treatment: A Post-Pandemic Educational Curriculum MedPointsTM in Multiple Sclerosis DMTs and COVID-19 is organized by Catamount Medical Education, Consortium of Multiple Sclerosis Centers (CMSC).
Release date: March 30, 2023
Expiration date: March 30, 2024
Learning Objectives
At the conclusion of this activity, participants should be better able to:
• Review evidence and recommendations related to DMTs and vaccine response, including to COVID-19 vaccines, in people with MS
Additional details will be posted as soon as information is available.
ACCREDITATION & CREDITS
Accreditation
In support of improving patient care, this activity has been planned and implemented by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Credit Designation
Physicians
The CMSC designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The CMSC designates this activity for a maximum of 0.5 NCPD credit (0.5 in the area of pharmacology).
Pharmacists
This knowledge-based activity, UAN JA4008165-9999-23-005-H01-P qualifies for 0.5 contact hours (0.05 CEUs) of continuing pharmacy education credit.
TARGET AUDIENCE
PhysicianNursingPharmacistNeurologistsSPECIALITIES
Neurology
Quick Links